Silence Therapeutics plc (SLNCF) Shareholders’ equity 2022–2025
Silence Therapeutics plc (SLNCF) shareholders’ equity at each fiscal year-end, per SEC filings.
$62.3MFY2025 · since FY2022: $27.2M → $62.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $62.3M | -53.5% |
| FY2024 | $134.0M | +509.4% |
| FY2023 | $22.0M | -19.2% |
| FY2022 | $27.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SLNCF financial trends
SLNCF RevenueSLNCF Net incomeSLNCF Net marginSLNCF Gross profitSLNCF Gross marginSLNCF Operating incomeSLNCF Operating marginSLNCF Operating cash flowSLNCF Free cash flowSLNCF Capital expendituresSLNCF Return on equitySLNCF Stock buybacksSLNCF Dividends paidSLNCF Total assetsSLNCF Total liabilitiesSLNCF overview →